Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2727-2732

  Pasche, Boris ^a   Luo, Yan ^a   Rao, Pulivarthi H ^a   Nimer, Stephen D ^a   Dmitrovsky, Ethan ^a   Caron, Philip ^a   Luzzatto, Lucio ^a   Offit, Kenneth ^a   Cordon Cardo, Carlos ^a   Renault, Béatrice ^c   Satagopan, Jaya M ^a   Murty, Vundavalli V V S ^d   Massagué, Joan ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Box 116 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL PROLIFERATION; CHROMOSOME 9Q; CHROMOSOME MAP; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; ALANINE; AMINO ACID SEQUENCE; BLOOD DONORS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CODON; COLONIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEQUENCE DELETION; URINARY BLADDER NEOPLASMS;

EID: 15444350405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sporn, M. B., and Roberts, A. B. TGF-β: problems and prospects. Cell Regul., 1: 875-882, 1990.
2. Massagué, J., Hata, A., and Liu, F. TGF-β signaling through the smad pathway. Trends Cell. Biol., 7: 187-192, 1997.
3. Heldin, C. H., Miyazono, K., and Tendijke, P. TGF-β signalling from cell membrane to nucleus through smad proteins. Nature (Lond.), 390: 465-471, 1997.
4. Mathew, S., Murty, V. V., Cheifetz, S., George, D., Massagué, J., and Chaganti, R. S. Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics, 20: 114-115, 1994.
5. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., and Vogelstein, B. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
6. Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., and Lodish, H. F. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol., 16: 3480-3489, 1996.
7. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
8. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., Dacosta, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. S., Hrubeh, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
9. Barrett, M. T., Schutte, M., Kern, S. E., and Reid, B. J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res., 56: 4351-4353, 1996.
10. Kim, S. K., Fan, Y., Papadimitrakopoulou, V., Clayman, G., Hittelman, W. N., Hong, W. K., Lotan, R., and Mao, L. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res., 56: 2519-2521, 1996.
11. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
12. Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56: 2718-2720, 1996.
13. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. Madr2 maps to 18q21 and encodes a TGF-β-regulated mad-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
14. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. L., Hamilton, S. R., Willson, J. K. V., Markowitz. S. D., Kinzler, K. W., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
15. Uchida, K., Nagatake, M., Osada, H., Yatabe, Y., Kondo, M., Mitsudomi, T., Masuda, A., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the jv18-1 gene at 18q21 in human lung cancers. Cancer Res., 56: 5583-5585, 1996.
16. DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F., and Kadin, M. E. Loss of functional cell surface transforming growth factor β (TGF-β) type I receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 94: 5877-5881, 1997.
17. Wang, J., Han, W., Zborowska, E., Liang, S., Wang, X., Willson, J. K. V., Sun, L., and Brattois, M. G. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem., 271: 17366-17371, 1996.
18. Kim, I. Y., Ahn, H. J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J. H., Kato, M., and Lee, C. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β-1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
19. Hoyle, C., Sherrington, P. D., and Hayhoe, F. G. J. Cytological features of 9q-deletions in AML. Br. J. Haematol., 66: 277-278, 1987.
20. Sreekantaiah, C., Baer, M. R., Preisler, H. D., and Sandberg, A. A. Involvement of bands 9q21-q22 in five cases of acute nonlymphocytic leukemia. Cancer Genet. Cytogenet., 39: 55-64, 1989.
21. Hirst, W. J. R., Czepulkowski, B., and Mufti, G. J. Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites. Cancer Genet. Cytogenet., 65: 51-57, 1993.
22. Mitelman, F., Mertens, F., and Johansson, B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet., 15: 417-474, 1997.
23. Miller, W. H., Jr., Kakizuka, A., Frankel, S. R., Warrell, R. P., Jr., DeBlasio, A., Levine, K., Evans, R. M., and Dmitrovsky, E. Reverse transcription poly-merase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 89: 2694-2698, 1992.
24. Laiho, M., Weis, F. M., Boyd, F. T., Ignotz, R. A., and Massagué, J. Responsiveness to TGF-β restored by genetic complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem., 266: 9108-9112, 1991.
25. Cárcamo, J., Weis, F. M., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., and Massagué, J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol., 14: 3810-3821, 1994.
26. Franzén, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., and Heldin, C-H. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell, 75: 681-692, 1993.
27. Boyd, F. T., and Massagué, J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kda membrane receptor. J. Biol. Chem., 264: 2272-2278, 1989.
28. Weis-Garcia, F., and Massagué, J. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J., 15: 276-289, 1996.
29. Carcamo, J., Zentella, A., and Massagué, J. Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol., 15: 1573-1581, 1995.
30. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
31. Johnson, D. W., Qumsiyeh, M., Benkhalifa, M., and Douglas, D. A. Assignment of human transforming growth factor-β type I and type III receptor genes (TGFBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively. Genomics, 28: 356-357, 1995.
32. Kaneko, H., Horiike, S., Taniwaki, M., and Misawa, S. Microsatellite instability is an early genetic event in myelodysplastic syndrome but is infrequent and not associated with TGF-β receptor type II gene mutation. Leukemia (Baltimore), 10: 1696-1699, 1996.